Table 2.
Medical treatment on admission according to 90-day readmission in septic patients
| Medication, N(%) | Readmitted N = 237 (35.8%) |
Not readmitted N = 425 (64.2%) |
Difference (95% CI) |
|---|---|---|---|
| Cardiac | |||
| Beta-blockersa | 75 (31.7) | 112 (26.4) | 5.3(÷2.0–12.6) |
| Calcium antagonistsa | 42 (17.7) | 90 (21.2) | 3.5(÷9.7–2.7) |
| Digoxina | 14 (5.9) | 15 (3.5) | 2.4(÷1.1–5.9) |
| ACE-inhibitors/AII-antagonistsa | 82 (34.6) | 137 (32.2) | 2.4(÷5.1–9.9) |
| Anticoagulantsb,c | 126 (53.2) | 190 (44.7) | 8.5 (0.6–16.4) |
| Diureticsb | 126 (53.2) | 167 (39.3) | 13.9 (6.0–21.8) |
| Lipid lowering drugsa | 79 (33.3) | 119 (28.0) | 5.3(÷2.0–12.7) |
| Pulmonary | |||
| Inhalation medicationsa | 58 (24.5) | 89 (20.9) | 3.6(÷3.1–10.3) |
| Diabetes | |||
| Insulin/peroral antidiabeticsa | 42 (17.7) | 74 (17.4) | 0.3(÷5.7–6.3) |
| Psychopharmacology medicationa,d | 42 (17.7) | 75 (17.7) | 0 |
| Analgesic | |||
| Opioidsb | 51 (21.5) | 62 (14.6) | 6.9 (0.7–13.1) |
| Other analgesicsa,e | 78 (32.9) | 147 (34.4) | 1.5(÷9.0–6.0) |
ACE Angiotensin-converting enzyme (ACE) inhibitors, AII angiotensin II receptor antagonists, CI confidence interval
aNinety-five percent CI for the difference of proportions included zero
bNinety-five percent CI for the difference of proportions did not include zero
cAcetylsalicylic acid, Non-Vitamin K antagonist oral anticoagulants, Warfarine/Dicoumarol
dAntipsychotics, Lithium, antidepressants, benzodiazepines
eParacetamol, caffeine-phenazon, codeine, non-steroidal anti-inflammatory drugs, others